Gas Chromatography – UV Spectrometry

Gas Chromatography-Ultraviolet (GC-UV) spectrometry is a powerful analytical technique used to separate and quantify components of complex mixtures, primarily in gaseous or volatile liquid samples. It combines the separation capabilities of gas chromatography with the detection capabilities of ultraviolet (UV) spectrometry to provide valuable information about the composition of a sample. 

Each breath you take contains a mosaic of volatile organic compounds (VOCs) – tiny chemical molecules that emanate from various metabolic processes within your body. These VOCs serve as potent indicators of your health status, capturing a snapshot of your internal workings. Just as a fingerprint is distinct to an individual, the composition of these VOCs in your breath is distinct to you, forming a distinctive “breathprint.” By extracting the breath using the AlitoBreasor ™ and then analyzing the collection tubes enable fast detection of the VOC biomarkers.

INSCAN 175™

Imagine a simple breath holding the power to reveal intricate details about your health, acting as a unique fingerprint that guides medical diagnoses. Recent scientific advancements have illuminated the remarkable potential of analyzing exhaled breath as a groundbreaking tool for detecting severe diseases, including cancer and periodontal diseases. 

Prioritized Products and Research Focus

Labio Medical is dedicated to pioneering transformative advancements in healthcare through its visionary approach to breath analysis among other interested research focus initatives. With a core focus on enhancing patient well-being, our mission is twofold: developing a revolutionary breath mask capable of accurately collecting breath samples, and crafting cutting-edge diagnostic kits that harness the power of breath to enable precise disease detection.

As we strive to redefine healthcare paradigms, Labio Medical remains resolute in its pursuit of advancing the science of breath analysis. Our journey is marked by a resounding commitment to innovation, patient-centricity, and the transformation of health assessment as we know it.